Analysis-Dealmakers grapple with unprecedented U.S. challenge to mergers
Send a link to a friend
[December 27, 2022] By
Anirban Sen and Diane Bartz
NEW YORK/WASHINGTON (Reuters) - Investment bankers and deal lawyers
accustomed to regulatory hurdles to their mergers face an unprecedented
challenge under U.S. President Joe Biden - antitrust watchdogs who are
undaunted when they lose such battles in court.
The U.S. Justice Department and Federal Trade Commission (FTC) have
attempted to thwart 22 mergers since Biden came into office in January
2021, according to a Reuters review of announcements from the agencies.
That outnumbers the antitrust challenges during the first two years of
former President Barack Obama's first term in office and is twice as
many as in Donald Trump's first two years, the Reuters analysis shows.
While comprehensive data going back decades is unavailable, Joel
Grosberg, an antitrust lawyer at McDermott, Will & Emery LLP, said more
mergers are entangled in U.S. antitrust litigation now than at any point
in his 25-year career.
"It's a combination of the FTC and (Justice Department) being willing to
litigate and the fact that companies are fighting back," Grosberg said.
The regulators managed to stop 15 out of the 22 deals, many without a
court fight as companies gave up and walked away from their agreement.
More recently, they have lost four attempts to block mergers in court,
though they are appealing two of the cases.
These losses have not soured regulators' appetite for challenging
mergers. Biden's appointees - FTC Chair Lina Khan and DoJ antitrust
chief Jonathan Kanter - are pressing on, arguing that corporate
consolidation has gone too far, harming consumers and workers at a time
of rampant inflation.
"Without question, what is clear about this team compared to their
predecessors is that they are not haunted by the possibility that they
might lose these cases," said former FTC chair and George Washington
University Law School antitrust professor William Kovacic.
Kanter told U.S. lawmakers in September his department would not "back
down from bringing meritorious cases." In a letter in August, Khan told
Senator Elizabeth Warren she believed asset sales to remedy competition
issues with mergers frequently fell short.
In response to a request for comment, an FTC spokesperson referred
Reuters to recent comments that Khan made in her congressional testimony
in September about the effects of past consolidation and the need for
stronger enforcement.
The Justice Department did not immediately respond to requests for
comment.
[to top of second column] |
Microsoft logo is seen on a smartphone
placed on displayed Activision Blizzard logo in this illustration
taken January 18, 2022. REUTERS/Dado Ruvic/Illustration/File Photo
The biggest deal currently at stake is Microsoft Corp's $69 billion
bid for "Call of Duty" maker Activision Blizzard Inc. The FTC has
sued to stop it, arguing it would allow Microsoft's Xbox to get
exclusive access to Activision games and put it in a position to
dominate the gaming market. Microsoft is fighting back and last week
told a judge the deal would benefit gamers and gaming companies
alike.
Cary Kochman, global co-head of M&A at Citigroup, said deals are
taking longer to be approved, forcing companies to "dribble the
ball" and "delay engagement on potential transactions" until the
regulatory landscape becomes clearer." Citigroup was not an advisor
on the Microsoft-Activision deal.
BRACING FOR BATTLE
Bankers and lawyers are advising merger partners to prepare for long
battles with regulators. They are pushing for contracts with more
time to complete a deal, to account for the possibility of antitrust
lawsuits.
"As you're negotiating things like interim operating covenants that
govern what you can and cannot do between signing and closing, you
should view them through the lens of having to live with them for 12
to 18 months in some cases," said Melissa Sawyer, global head of the
M&A group at law firm Sullivan & Cromwell.
Break-up fees that acquirers agree to pay their targets if their
deal gets shot down by antitrust regulators are also on the rise.
This year's U.S. total of $22.6 billion accounts for 4.6% of deal
value, according to Refinitiv, the highest level since the first
eight months of 2013, when dealmakers worried about Obama's
antitrust crackdown.
Many companies facing merger challenges say they will fight on,
emboldened by the four court losses of the Justice Department and
FTC. These include lawsuits to thwart health insurer UnitedHealth
Group Inc's $8 billion bid to buy health-technology firm Change
Healthcare and life sciences company Illumina Inc 's $7.1 billion
acquisition of cancer test developer Grail.
"For the vast majority of deals, when we assess them from an
antitrust perspective, we as advisors believe those deals can get
done," said Edward Lee, corporate partner at law firm Kirkland &
Ellis.
(Reporting by Anirban Sen in New York and Diane Bartz in Washington
DC; Editing by Greg Roumeliotis and Richard Chang)
[© 2022 Thomson Reuters. All rights
reserved.]
This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |